The crosstalk between IL-6-producing GBM cells and BBB cells, which activate STAT3, simultaneously decreased ABC transporters and TJ proteins, thus increasing BBB permeability to different chemotherapeutic drugs virtually BBB-impermeant. The gene discussed is STAT3; the disease is glioblastoma.